Search | IOVS | ARVO Journals

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

A comparison of human stem cell-retinal organoid protocols as a way to investigate the timing and regulation of RS1 protein

Andrea Heredero; Philip E Wagstaff; Anneloor L M A Ten Asbroek; Jacoline B ten Brink; Arthur A. Bergen; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2428 – F0372. doi:

ARVO Annual Meeting Abstract June 2021

Dynamic BMP Gene Expression Regulation in Chick RPE During Recovery from Lens-Induced Defocus and Form-Deprivation

Yan Zhang; Qiurong Zhu; Wulian Song; Grace May Chuang; Daniel Sun; Kiana Cheung; Andreana Chou; Andrea He; Christine F Wildsoet

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2280. doi:

ARVO Annual Meeting Abstract July 2019

Brimonidine loaded lipid DNA-nanoparticles as an improved and novel treatment option for glaucoma

Sven Schnichels; Katharina Frößl; Jan Willem de Vries; Marina Löscher; Karl Bartz-Schmidt; Andreas Herrmann; Martin S Spitzer; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1703. doi:

ARVO Annual Meeting Abstract July 2018

DNA Nanoparticles for the Treatment of Retinal Diseases: in-vivo results

Sven Schnichels; David Simmang; Lisa Strudel; Jose Hurst; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5683. doi:

ARVO Annual Meeting Abstract July 2018

Lipid DNA Nanoparticles – a versatile vehicle for anterior segment drug delivery

Lisa Strudel; Jose Hurst; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5684. doi:

ARVO Annual Meeting Abstract July 2018

The development of pigmentation in new tissue arises from precursor and not migratory melanocytes in a transgenic GNAQ Q209L zebrafish model of uveal melanoma

Andrea M. Henle; Josey Muske; Michael Poplawski; Tanisha Perlmutter

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3177. doi:

ARVO Annual Meeting Abstract June 2017

Travoprost loaded lipid DNA-nanoparticles as a new and improved treatment for glaucoma

Sven Schnichels; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Sascha Dammeier; Andreas Herrmann; Martin Stephan Spitzer; Jose Hurst

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4105. doi:

ARVO Annual Meeting Abstract June 2017

Lipid modified aptamers as vehicles for ophthalmic drug delivery

Lisa Strudel; Jose Hurst; Agnieszka Gruszka; Ullrich Hagel; Jan Willem de Vries; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4107. doi:

ARVO Annual Meeting Abstract September 2016

In-vitro and in-vivo toxicological evaluation of alkyl-modified DNA nanoparticles

Katharina Froessl; Jan Willem De Vries; Johanna Wude; Jose Hurst; Agnieszka Gruszka; Karl-Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5054. doi:

ARVO Annual Meeting Abstract September 2016

Kanamycin loaded lipid modified DNA-Nanoparticles with superior bacterial growth inhibition

Lisa Strudel; Jose Hurst; Jan Willem De Vries; Agnieszka Gruszka; Karl-Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5055. doi:

ARVO Annual Meeting Abstract June 2015

Quantitative comparison and toxicological evaluation of DNA-based nanoparticles for the treatment of anterior eye segment diseases

Jan Willem De Vries; Martin Stephan Spitzer; Agnieszka Gruszka; Aileen Breitschwerdt; Patricia Deissenroth; Johanna Hofmann; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1538. doi:

ARVO Annual Meeting Abstract June 2015

Efficacy & functionality of antibiotic delivery through DNA based nanoparticles

Sven Schnichels; Martin Stephan Spitzer; Lisa Strudel; Jose Hurst; Agnieszka Gruszka; Patricia Deissenroth; Sascha Dammeier; Karl Ulrich Bartz-Schmidt; Andreas Herrmann; Jan Willem De Vries

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1539. doi:

ARVO Annual Meeting Abstract June 2015

Lipid DNA Nanoparticles as a new type of medication carrier platform for the treatment of retinal diseases

David Simmang; Sven Schnichels; Jan Willem De Vries; Jose Hurst; Karl Ulrich Bartz-Schmidt; Andreas Hermann; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5027. doi:

ARVO Annual Meeting Abstract April 2014

Enhanced antibiotic delivery through DNA-based nanoparticles

Martin Stephan Spitzer; Sven Schnichels; Lisa Strudel; Johanna Hofmann; Karl U Bartz-Schmidt; Andreas Hermann; Jan Willem de Vries

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2162. doi:

ARVO Annual Meeting Abstract April 2014

DNA-based nanoparticles as potential drug carriers for the treatment of anterior segment diseases

Sven Schnichels; Jan Willem de Vries; Lisa Strudel; Minseok Kwak; Johanna Hofmann; Karl U Bartz-Schmidt; Martin Stephan Spitzer; Andreas Hermann

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):468. doi:

ARVO Annual Meeting Abstract June 2013

Clouding of intraocular silicone oil in the absence of emulsification

Martin Spitzer; Jan Willem de Vries; Andreas Herrmann; Karl-Ulrich Bartz-Schmidt; Sascha Dammeier

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3316. doi:

ARVO Annual Meeting Abstract April 2011

Influence Of Early Amniotic Membrane And Mesenchymal Stem Cell Transplantation On The Clinical Outcome After Severe Corneal Burn In Rats

Andreas Heidt; Philipp Eberwein; Daniel Böhringer; Johannes Schwartzkopff; Yvonne Kern; Thomas Reinhard

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1992. doi:

Advertisement